Piras, A.; Laudicella, R.; Boldrini, L.; D’Aviero, A.; Sanfratello, A.; La Rocca, A.; Scurria, S.; Salamone, G.; Alongi, P.; Angileri, T.;
et al. The Added Value of [18F]Choline PET/CT in Low-Risk Prostate Cancer Staging: A Case Report. Life 2022, 12, 1728.
https://doi.org/10.3390/life12111728
AMA Style
Piras A, Laudicella R, Boldrini L, D’Aviero A, Sanfratello A, La Rocca A, Scurria S, Salamone G, Alongi P, Angileri T,
et al. The Added Value of [18F]Choline PET/CT in Low-Risk Prostate Cancer Staging: A Case Report. Life. 2022; 12(11):1728.
https://doi.org/10.3390/life12111728
Chicago/Turabian Style
Piras, Antonio, Riccardo Laudicella, Luca Boldrini, Andrea D’Aviero, Antonella Sanfratello, Antonino La Rocca, Salvatore Scurria, Giuseppe Salamone, Pierpaolo Alongi, Tommaso Angileri,
and et al. 2022. "The Added Value of [18F]Choline PET/CT in Low-Risk Prostate Cancer Staging: A Case Report" Life 12, no. 11: 1728.
https://doi.org/10.3390/life12111728
APA Style
Piras, A., Laudicella, R., Boldrini, L., D’Aviero, A., Sanfratello, A., La Rocca, A., Scurria, S., Salamone, G., Alongi, P., Angileri, T., & Daidone, A.
(2022). The Added Value of [18F]Choline PET/CT in Low-Risk Prostate Cancer Staging: A Case Report. Life, 12(11), 1728.
https://doi.org/10.3390/life12111728